Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*.
Kowalski ML, Makowska JS, Blanca M, Bavbek S, Bochenek G, Bousquet J, Bousquet P, Celik G, Demoly P, Gomes ER, Niżankowska-Mogilnicka E, Romano A, Sanchez-Borges M, Sanz M, Torres MJ, De Weck A, Szczeklik A, Brockow K.
Allergy. 2011 Jul;66(7):818-29. doi: 10.1111/j.1398-9995.2011.02557.x. Epub 2011 Feb 14.
[Sulfite hypersensitivity].
Przybilla B, Ring J.
Hautarzt. 1987 Aug;38(8):445-8.
[Late reaction in asthma].
Solèr M.
Schweiz Med Wochenschr. 1989 Feb 25;119(8):237-42.
[Preventive immunotherapy].
Boquete M, Carballada F, Expósito F, González A.
Allergol Immunopathol (Madr). 2000 May-Jun;28(3):89-93.
Cetirizine: more than an antihistamine?
Bernheim J, Arendt C, de Vos C.
Agents Actions Suppl. 1991;34:269-93.
Proceedings: Inhibition of the immediate reaction to inhaled allergen in asthma by a new compound.
Haydu SP.
Tubercle. 1975 Jun;56(2):172. doi: 10.1016/0041-3879(75)90047-1.
Allergy, Histamine and Antihistamines.
Church MK.
Handb Exp Pharmacol. 2017;241:321-331. doi: 10.1007/164_2016_85.
The mechanism of corticosteroids in treating asthma.
Townley RG, Suliaman F.
Ann Allergy. 1987 Jan;58(1):1-6.
Leucocytes in asthma.
Kay AB.
Immunol Invest. 1988 Nov-Dec;17(8-9):679-705. doi: 10.3109/08820138809089018.
Piperazine-induced occupational asthma.
Hagmar L, Bellander T, Bergöö B, Simonsson BG.
J Occup Med. 1982 Mar;24(3):193-7.
